PANLUMINATE INC.

Medtech · Private

Automated light-sheet microscope with AI-driven image analysis software for 3D multiplexed protein imaging and sub-organelle segmentation at nanoscale resolution

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Total capital: $6.1M

Federal grants: $6.1M; 9 awards · 2022–2026; Rank in peer group#93 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Jun 2026Federal grantHealth and Human S · Phase II · pan-XLSM: an AI-powered microscopy platform for imaging and analysis of highly expanded tissue samples$1.1M
Sep 2025Federal grantHealth and Human S · Phase I · FLASH-pulse: A versatile multiplexed tissue imaging solution for research on aging$398K
Aug 2025Federal grantHealth and Human S · Phase II · A 3D super-resolved platform for rapid and highly multiplexed proteomics$726K
Aug 2025Federal grantHealth and Human S · Phase II · pan-XLSM: an AI-powered microscopy platform for imaging and analysis of highly expanded tissue samples$1.4M
Jul 2025Federal grantHealth and Human S · Phase I · High-throughput spatial proteomics in pulmonary research with FLASH multiplex imaging$312K
Jun 2025Federal grantHealth and Human S · Phase I · Development of ChromEx30 for Nanoscale Imaging of Genetic Organization and Disease Phenotypes$404K
Sep 2024Federal grantHealth and Human S · Phase II · A 3D super-resolved platform for rapid and highly multiplexed proteomics$1.2M

Show 2 earlier federal awards

Sep 2023Federal grantHealth and Human S · Phase I · Development of a sample preparation protocol for 3D kidney ultrastructural analysis and immunolabeling by light microscopy$274K
Sep 2022Federal grantHealth and Human S · Phase I · Development of a sample preparation protocol for brain ultrastructural analysis, immunolabeling, and neuronal tracing by light microscopy$249K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#93 · top 17%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

APPLIED BIOSENSORS, LLCSimilar federal contract value in Medtech · null in contracts
ATHARVA, LLCSimilar federal contract value in Medtech · null in contracts
MIRO HEALTH INCSimilar federal contract value in Medtech · null in contracts
MDDRIVEN LLCSimilar federal contract value in Medtech · null in contracts
BIOXYTECH RETINA INCSimilar federal contract value in Medtech · null in contracts
BRAINCHILD TECHNOLOGIES, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.